(Q34169269)

31 July 2017

1 reference

title

Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2. (English)

1 reference

31 July 2017

1 reference

Armstrong WS

1

1 reference

PubMed ID

11229845

31 July 2017

Kazanjian P

series ordinal

2

1 reference

PubMed ID

11229845

31 July 2017

language of work or name

English

0 references

publication date

28 February 2001

1 reference

Clinical Infectious Diseases

31 July 2017

1 reference

31 July 2017

32

1 reference

31 July 2017

766-773

1 reference

31 July 2017

5

1 reference

Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor

31 July 2017

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients

21 January 2018

1 reference

Induction of granulocyte colony-stimulating factor by acute febrile infection but not by neutropenia in HIV-seropositive individuals

21 January 2018

1 reference

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

The use of GM-CSF in AIDS

21 January 2018

1 reference

Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.

21 January 2018

1 reference

Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection.

21 January 2018

1 reference

Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice

21 January 2018

1 reference

Killing of Mycobacterium avium by neutrophils and monocytes from AIDS patients treated with recombinant granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils

21 January 2018

1 reference

Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1.

21 January 2018

1 reference

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

21 January 2018

1 reference

Cytokines alter production of HIV-1 from primary mononuclear phagocytes

21 January 2018

1 reference

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

21 January 2018

1 reference

Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease

21 January 2018

1 reference

Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy

21 January 2018

1 reference

Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection

21 January 2018

1 reference

Human immunodeficiency virus infection, anemia, and survival

21 January 2018

1 reference

Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group

21 January 2018

1 reference

Recombinant human erythropoietin for patients with AIDS treated with zidovudine

21 January 2018

1 reference

Anemia and survival in HIV infection

21 January 2018

1 reference

Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects

21 January 2018

1 reference

Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.

21 January 2018

1 reference

Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients.

21 January 2018

1 reference

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

21 January 2018

1 reference

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

21 January 2018

1 reference

Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus load

21 January 2018

1 reference

A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection

21 January 2018

1 reference

A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.

21 January 2018

1 reference

Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group

21 January 2018

1 reference

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

21 January 2018

1 reference

Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS

21 January 2018

1 reference

Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/319227

1 reference

31 July 2017

1 reference

PubMed ID

11229845